Annals of Indian Academy of Neurology
CASE REPORT
Year
: 2019  |  Volume : 22  |  Issue : 3  |  Page : 325--327

Leukoencephalopathy in mitochondrial neurogastrointestinal encephalomyopathy-like syndrome with polymerase-gamma mutations


Hongyan Huang1, Xinglong Yang2, Ling Liu1, Yanming Xu1,  
1 Department of Neurology, West China Hospital, Sichuan University, Sichuan Province, PR China
2 Department of Geriatric Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, PR China

Correspondence Address:
Dr. Yanming Xu
Department of Neurology, West China Hospital, Sichuan University, 37 Guo Xue Xiang, Chengdu, Sichuan Province, 610041
PR China

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome, caused by mutations in the thymidine phosphorylase gene, manifests as a multisystemic disorder characterized by severe gastrointestinal dysmotility, cachexia, ptosis and ophthalmoparesis, peripheral neuropathy, and leukoencephalopathy. These clinical manifestations, with the exception of leukoencephalopathy, are mimicked by MNGIE-like syndrome, linked to polymerase-gamma (POLG) gene. Here, we report a 49-year-old Chinese man with MNGIE-like syndrome involved leukoencephalopathy and was associated with novel POLG mutations. This case expands the clinical spectrum of MNGIE-like syndrome.



How to cite this article:
Huang H, Yang X, Liu L, Xu Y. Leukoencephalopathy in mitochondrial neurogastrointestinal encephalomyopathy-like syndrome with polymerase-gamma mutations.Ann Indian Acad Neurol 2019;22:325-327


How to cite this URL:
Huang H, Yang X, Liu L, Xu Y. Leukoencephalopathy in mitochondrial neurogastrointestinal encephalomyopathy-like syndrome with polymerase-gamma mutations. Ann Indian Acad Neurol [serial online] 2019 [cited 2019 Dec 9 ];22:325-327
Available from: http://www.annalsofian.org/text.asp?2019/22/3/325/243800


Full Text



 Introduction



Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome is caused by mutations in the thymidine phosphorylase (TYMP) gene that lead TYMP deficiency and elevated plasma thymidine levels.[1] Clinical manifestations include severe gastrointestinal dysmotility, cachexia, ptosis and ophthalmoparesis, peripheral neuropathy, and leukoencephalopathy.[1] Patients with a clinical phenotype indistinguishable from MNGIE have been reported in the absence of TYMP gene mutations; their condition has been called MNGIE-like syndrome.[2],[3],[4],[5],[6] A handful of cases of MNGIE-like syndrome have been reported in association with polymerase-gamma (POLG) gene.[2],[3],[4] van Goethem et al. first described two sisters with clinical features mimicking MNGIE linked to mutations in POLG.[2] Tang et al.[3] and Prasun et al.[4] reported four patients presenting MNGIE with mutations in POLG. All cases shared similar brain magnetic resonance imaging (MRI) findings indicating the absence of leukoencephalopathy.[2],[3],[4] Here, we report, for the first time, a patient with MNGIE-like syndrome involving leukoencephalopathy and associated with novel POLG mutations.

 Case Report



The Chinese male had a history of good health until 42 years old when he developed mild gastrointestinal dysmotility leading to diarrhea and episodes of abdominal pain. At age 48, he was hospitalized for ptosis, diplopia, and weakness in the extremities. At the same time, gastrointestinal manifestations developed significantly, such that he began to suffer chronic diarrhea and persistent abdominal distention, leading to loss of 22 kg.

Colonoscopy revealed colonic diverticulum. Abdominal computed tomography showed gastroduodenal expansion. Peripheral nerve conduction velocity findings were consistent with demyelinating and axonal sensory motor neuropathy. Protein in the cerebrospinal fluid was elevated (119 mg/dL; normal: 15–45 mg/dL) while no leukocytes were detected. The patient was initially diagnosed with chronic inflammatory demyelinating polyneuropathy and given corticosteroids and intravenous immunoglobulin. These treatments had no effect.

At age 49, the patient was hospitalized again for progressive limb weakness. His appearance was cachectic, body mass index was 13.8 kg/m2, and he showed muscle atrophy. Neurological examination showed ophthalmoplegia, ptosis, muscle weakness, and absence of deep tendon reflexes. In light of his disease course, we suspected that he suffered from MNGIE or MNGIE-like syndrome.

Subsequently, we arranged the muscle biopsy, and the result revealed ragged-red fibers and cytochrome oxidase (COX)-negative fibers. Brain MRI showed bilateral periventricular white matter hyperintensities in fluid-attenuated inversion recovery and T2-weighted images [Figure 1]. The medical history of the patient did not suggest alternative causes of leukoencephalopathy, such as intoxication, infections, or hypertension. Next-generation sequencing of mitochondrial and nuclear genomes from skeletal muscle tissues identified two novel heterozygous variants in POLG: c.3643 + 1G > A (splicing), near exon 23 and c.2396C > A (p. S799Y), in exon 14. These mutations are located in the polymerase domain and were verified by direct DNA sequencing.{Figure 1}

Neither variant was found in any of the databases consulted, including dbSNP, HapMap, and 1000 Genomes, or among 500 healthy Chinese samples. Protein function prediction using Polyphen-2, SIFT, and MutationTaster suggested that the missense variant is likely to be damaging.

 Discussion



Here, we report a Chinese man with clinical features of MNGIE. Histological examination showed ragged-red fibers and COX-negative fibers. Moreover, the clinical manifestations could not be attributed to other phenotypes of POLG-related disorders, such as Alpers-Huttenlocher syndrome, myoclonic epilepsy myopathy sensory ataxia, ataxia neuropathy spectrum, or chronic progressive external ophthalmoplegia.[7]

The patients carried two novel variants in POLG which were not detected in 500 normal control DNA samples. We considered the two variants are likely pathogenic. Other POLG mutations have been shown to cause MNGIE-like syndrome through autosomal recessive or dominant transmission.[2],[3],[4] The patient has no family history. We do not know whether the two POLG variants in our patients occurred in trans since no DNA from their relatives was available. Further work is needed to establish a clear genotype–phenotype correlation and to confirm the pathogenicity of these two novel POLG variants.

The leukoencephalopathy in our patient appeared as patchy white matter lesions in contrast to the confluent leukoencephalopathy usually observed in MNGIE.[8] In recent years, white matter lesions have been increasingly recognized in mitochondrial disorders.[9] Other mutations in the POLG gene have similarly been linked to leukoencephalopathy, such as in Alpers syndrome.[9],[10] Encephalopathy is closely related to mitochondrial dysfunction resulting in energy deficiency.[9]

To our knowledge, this is the first case of MNGIE-like syndrome with leukoencephalopathy involving POLG variants. Our findings expand the clinical spectrum of MNGIE-like syndrome linked to POLG variants and challenge the previous view that the presence or absence of leukoencephalopathy differentiates MNGIE from MNGIE-like syndrome associated with POLG variants.[2],[3],[4]

Diagnosis of MNGIE or MNGIE-like is challenging. Appropriate attention to gastrointestinal manifestations and brain MRI may help identify these syndromes in the early stage.

What is Known?

Polymerase-gamma gene mutations have been linked to mitochondrial neurogastrointestinal encephalomyopathy-like (MNGIE-like) syndrome, which shares the manifestations of classical MNGIE syndrome except leukoencephalopathy.

What is New?

Two novel polymerase-gamma mutations have been linked to mitochondrial neurogastrointestinal encephalomyopathy-like syndrome that involves leukoencephalopathy.

Acknowledgments

We wish to acknowledge the patient and his family for their participation in this study and their efforts to help us.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Hirano M, Nishigaki Y, Martí R. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): A disease of two genomes. Neurologist 2004;10:8-17.
2Van Goethem G, Schwartz M, Löfgren A, Dermaut B, Van Broeckhoven C, Vissing J, et al. Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 2003;11:547-9.
3Tang S, Dimberg EL, Milone M, Wong LJ. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: An expanded clinical spectrum of POLG1 mutations. J Neurol 2012;259:862-8.
4Prasun P, Koeberl DD. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype in a patient with a novel heterozygous POLG mutation. J Neurol 2014;261:1818-9.
5Shaibani A, Shchelochkov OA, Zhang S, Katsonis P, Lichtarge O, Wong LJ, et al. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 2009;66:1028-32.
6Lehnhardt FG, Horvath R, Ullrich R, Kracht L, Sobesky J, Möller-Hartmann W, et al. Altered cerebral glucose metabolism in a family with clinical features resembling mitochondrial neurogastrointestinal encephalomyopathy syndrome in association with multiple mitochondrial DNA deletions. Arch Neurol 2008;65:407-11.
7Stumpf JD, Saneto RP, Copeland WC. Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol 2013;5:a011395.
8Scarpelli M, Ricciardi GK, Beltramello A, Zocca I, Calabria F, Russignan A, et al. The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy. Neuroradiol J 2013;26:520-30.
9Wong LJ. Mitochondrial syndromes with leukoencephalopathies. Semin Neurol 2012;32:55-61.
10Milone M, Wang J, Liewluck T, Chen LC, Leavitt JA, Wong LJ, et al. Novel POLG splice site mutation and optic atrophy. Arch Neurol 2011;68:806-11.